Former Biogen, Inc. R&D chief Al Sandrock is the new CEO of gene therapy specialist Voyager Therapeutics, Inc bringing extensive experience in neuroscience to the role but less gene therapy expertise. Voyager announced the appointment on 22 March, with Sandrock succeeding interim CEO Michael Higgins, who will remain chairman of the board.
The news comes just weeks after Sandrock joined Voyager's board of directors in February and a new executive committee aimed...








